Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy

Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology stands as a promising strategy for cancer immunotherapy. The physicochemical properties of nanoparticles (NPs) influence th...

Full description

Bibliographic Details
Main Authors: Jianbo Jia, Yi Zhang, Yan Xin, Cuijuan Jiang, Bing Yan, Shumei Zhai
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00404/full
id doaj-92708de982044bc192dc1a5c7357d325
record_format Article
spelling doaj-92708de982044bc192dc1a5c7357d3252020-11-24T21:33:22ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2018-09-01810.3389/fonc.2018.00404410678Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer ImmunotherapyJianbo Jia0Yi Zhang1Yan Xin2Cuijuan Jiang3Bing Yan4Bing Yan5Shumei Zhai6Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Institute of Environmental Research at Greater Bay, Guangzhou University, Guangzhou, ChinaSchool of Chemistry and Chemical Engineering, Shandong University, Jinan, ChinaSchool of Chemistry and Chemical Engineering, Shandong University, Jinan, ChinaSchool of Environmental Science and Engineering, Shandong University, Jinan, ChinaKey Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Institute of Environmental Research at Greater Bay, Guangzhou University, Guangzhou, ChinaSchool of Environmental Science and Engineering, Shandong University, Jinan, ChinaSchool of Chemistry and Chemical Engineering, Shandong University, Jinan, ChinaDendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology stands as a promising strategy for cancer immunotherapy. The physicochemical properties of nanoparticles (NPs) influence their interactions with DCs, thus altering the immune outcome of DCs by changing their functions in the processes of maturation, homing, antigen processing and antigen presentation. In this review, we summarize the recent progress in targeting DCs using NPs as a drug delivery carrier in cancer immunotherapy, the recognition of NPs by DCs, and the ways the physicochemical properties of NPs affect DCs' functions. Finally, the molecular pathways in DCs that are affected by NPs are also discussed.https://www.frontiersin.org/article/10.3389/fonc.2018.00404/fullnanoparticlesphysicochemical propertiesDC targetingcancer immunotherapyDC functions
collection DOAJ
language English
format Article
sources DOAJ
author Jianbo Jia
Yi Zhang
Yan Xin
Cuijuan Jiang
Bing Yan
Bing Yan
Shumei Zhai
spellingShingle Jianbo Jia
Yi Zhang
Yan Xin
Cuijuan Jiang
Bing Yan
Bing Yan
Shumei Zhai
Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
Frontiers in Oncology
nanoparticles
physicochemical properties
DC targeting
cancer immunotherapy
DC functions
author_facet Jianbo Jia
Yi Zhang
Yan Xin
Cuijuan Jiang
Bing Yan
Bing Yan
Shumei Zhai
author_sort Jianbo Jia
title Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
title_short Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
title_full Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
title_fullStr Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
title_full_unstemmed Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
title_sort interactions between nanoparticles and dendritic cells: from the perspective of cancer immunotherapy
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2018-09-01
description Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology stands as a promising strategy for cancer immunotherapy. The physicochemical properties of nanoparticles (NPs) influence their interactions with DCs, thus altering the immune outcome of DCs by changing their functions in the processes of maturation, homing, antigen processing and antigen presentation. In this review, we summarize the recent progress in targeting DCs using NPs as a drug delivery carrier in cancer immunotherapy, the recognition of NPs by DCs, and the ways the physicochemical properties of NPs affect DCs' functions. Finally, the molecular pathways in DCs that are affected by NPs are also discussed.
topic nanoparticles
physicochemical properties
DC targeting
cancer immunotherapy
DC functions
url https://www.frontiersin.org/article/10.3389/fonc.2018.00404/full
work_keys_str_mv AT jianbojia interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT yizhang interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT yanxin interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT cuijuanjiang interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT bingyan interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT bingyan interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
AT shumeizhai interactionsbetweennanoparticlesanddendriticcellsfromtheperspectiveofcancerimmunotherapy
_version_ 1725953629385392128